SEARCH RESULTS

12 RESULTS

Philip Scheltens on A New Era of Alzheimer’s Treatment

COMMENT Overall, the FDA decision is a good thing for patients, the field, and the industry/investment community. I believe this for two reasons: The accelerated approval acknowledges the severity, fatality, and lack of treatment of Alzheimer’s, placing AD in the ...

Current Filters

  • TYPE: Comment x
  • Commentator: Scheltens, Philip x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE